CASI PHARMACEUTICALS INC (CASI) Stock Analyst Earnings Estimates
NASDAQ:CASI - Nasdaq - KYG1933S1012 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 30.17M 99.27% | 43.11M 42.89% | 33.879M -21.41% | 20.191M -40.40% | 47.407M 134.79% | 71.758M 51.37% | 91.252M 27.17% | 110.23M 20.80% | 130.14M 18.06% | 146.3M 12.42% | |
| EBITDA YoY % growth | -33.46M -6.70% | -24.07M 28.06% | -21.539M 10.52% | -23.347M -8.39% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -35.28M -5.88% | -26.49M 24.91% | -25.28M 4.57% | -36.435M -44.13% | -33.941M 6.85% | -28.963M 14.67% | -26.791M 7.50% | -22.497M 16.03% | -15.933M 29.18% | -11.865M 25.54% | |
| Operating Margin | -116.94% | -61.45% | -74.62% | -180.45% | -71.59% | -40.36% | -29.36% | -20.41% | -12.24% | -8.11% | |
| EPS YoY % growth | -2.70 35.71% | -3.40 -25.93% | -2.02 40.59% | -2.61 -29.27% | -2.17 16.80% | -1.79 17.84% | 0.97 154.29% | 1.32 35.79% | 1.59 20.93% | 1.83 14.74% |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -0.61 -36.00% |
| Revenue Q2Q % growth | 7.542M 9.72% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -8.938M -158.41% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.55 -57.14% | -0.63 | 0.08 | 13.03% |
| Q2 2024 Q2Q % growth | -0.55 28.57% | -0.64 | 0.09 | 14.41% |
| Q1 2024 Q2Q % growth | -0.71 -57.78% | -0.05 | -0.66 | -1,292.16% |
| Q4 2023 Q2Q % growth | -0.45 75.81% | -0.24 | -0.21 | -83.82% |
| Q3 2023 Q2Q % growth | -0.35 7.89% | -0.57 | 0.22 | 38.73% |
| Q2 2023 Q2Q % growth | -0.77 -37.50% | -0.51 | -0.26 | -50.98% |
| Q1 2023 Q2Q % growth | -0.45 25.00% | -0.65 | 0.20 | 31.07% |
| Q4 2022 Q2Q % growth | -1.86 -365.00% | -0.38 | -1.48 | -392.85% |
| Q3 2022 Q2Q % growth | -0.38 45.71% | -0.47 | 0.09 | 19.59% |
| Q2 2022 Q2Q % growth | -0.56 -12.00% | -0.65 | 0.09 | 14.22% |
| Q1 2022 Q2Q % growth | -0.60 45.45% | -0.88 | 0.28 | 32.13% |
| Q4 2021 Q2Q % growth | -0.40 66.67% | -0.58 | 0.18 | 30.80% |
| Q3 2021 Q2Q % growth | -0.70 50.00% | -0.56 | -0.14 | -24.78% |
| Q2 2021 Q2Q % growth | -0.50 28.57% | -0.74 | 0.24 | 32.39% |
| Q1 2021 Q2Q % growth | -1.10 -22.22% | -0.61 | -0.49 | -79.74% |
| Q4 2020 Q2Q % growth | -1.20 | -0.71 | -0.49 | -68.07% |
| Q3 2020 Q2Q % growth | -1.40 -40.00% | -0.56 | -0.84 | -149.55% |
| Q2 2020 Q2Q % growth | -0.70 56.25% | -0.82 | 0.12 | 14.22% |
| Q1 2020 Q2Q % growth | -0.90 | -1.12 | 0.22 | 19.79% |
| Q4 2019 Q2Q % growth | -1.20 | -1.12 | -0.08 | -6.95% |
| Q3 2019 Q2Q % growth | -1.00 | -1.12 | 0.12 | 10.87% |
| Q2 2019 Q2Q % growth | -1.60 | -0.92 | -0.68 | -74.29% |
| Q1 2019 Q2Q % growth | -0.90 | -0.92 | 0.02 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 7.793M -11.82% | 4.651M | 3.142M | 67.56% |
| Q2 2024 Q2Q % growth | 3.979M -59.48% | 4.52M | -541K | -11.97% |
| Q1 2024 Q2Q % growth | 3.409M -59.16% | 12.24M | -8.831M | -72.15% |
| Q4 2023 Q2Q % growth | 6.874M -54.95% | 9.6M | -2.726M | -28.40% |
| Q3 2023 Q2Q % growth | 8.838M -13.44% | 10.608M | -1.77M | -16.69% |
| Q2 2023 Q2Q % growth | 9.82M 14.59% | 10.292M | -472K | -4.59% |
| Q1 2023 Q2Q % growth | 8.347M -7.87% | 9.282M | -935K | -10.07% |
| Q4 2022 Q2Q % growth | 15.259M 66.58% | 11.009M | 4.25M | 38.60% |
| Q3 2022 Q2Q % growth | 10.21M 25.89% | 10.098M | 112K | 1.11% |
| Q2 2022 Q2Q % growth | 8.57M 19.69% | 8.033M | 537K | 6.68% |
| Q1 2022 Q2Q % growth | 9.06M 57.84% | 9.418M | -358K | -3.80% |
| Q4 2021 Q2Q % growth | 9.16M 90.04% | 9.248M | -88K | -0.95% |
| Q3 2021 Q2Q % growth | 8.11M 91.27% | 7.689M | 421K | 5.48% |
| Q2 2021 Q2Q % growth | 7.16M 168.16% | 6.14M | 1.02M | 16.61% |
| Q1 2021 Q2Q % growth | 5.74M 68.33% | 5.151M | 589K | 11.43% |
| Q4 2020 Q2Q % growth | 4.82M 259.70% | 4.538M | 282K | 6.21% |
| Q3 2020 Q2Q % growth | 4.24M 51.97% | 3.512M | 728K | 20.73% |
| Q2 2020 Q2Q % growth | 2.67M | 3.825M | -1.155M | -30.20% |
| Q1 2020 Q2Q % growth | 3.41M | 803.76K | 2.606M | 324.26% |
| Q4 2019 Q2Q % growth | 1.34M | 1.184M | 156K | 13.18% |
| Q3 2019 Q2Q % growth | 2.79M | 738.48K | 2.052M | 277.80% |
| Q2 2019 Q2Q % growth | 862.92K | -862.92K | -100.00% | |
| Q1 2019 Q2Q % growth | 627.3K | -627.3K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | 0% | 0% | 0% | 0% |